# Cimilre Co., Ltd.

- Location (FDA's records): Cheonan-Si, KR
- FDA decisions: 3 (2017–2026): 3 510(k) clearances
- Product codes: HGX (3)
- 510(k) review time since 2016: median 175 days, against 159 for FDA's reviews in the same codes and years (1 of 3 faster)
- Predicates its devices cite: 3 (1 its own); citations of its devices by later devices: 3 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Uzinmedicare Co.: 1 (https://510kreport.com/company/uzinmedicare)
- Unimom.Co: 1 (https://510kreport.com/company/unimom)

## Firms that cite its devices most
- Guangzhou Yongyi Industrial Co., Ltd.: 1 (https://510kreport.com/company/guangzhou-yongyi-industrial)
- Ameda, Inc.: 1 (https://510kreport.com/company/ameda)

## Its most-cited devices
- K162870: CIMLRE F1 and CIMILRE S3 (2017), cited by 3

## Recent decisions
- K260643: Cimilre Dual Max (Aug 21, 2026)
- K221708: CIMILRE Free-T2 Plus (Dec 23, 2022)
- K162870: CIMLRE F1 and CIMILRE S3 (Mar 7, 2017)

Source page: https://510kreport.com/company/cimilre